ArticleBMC microbiology2017
Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.
Article in BMC microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 99 citations in OpenAlex.
- Novel AlphaPlex Design Enables Rapid Differentiation ofPathogens (Basel, Switzerland) · 2026Article
- First molecular characterization and antimicrobial resistance profiles of Campylobacter jejuni isolated from poultry meat in Yemen.Scientific reports · 2026Article
- Article
- Molecular epidemiology and genetic relatedness of zoonotic Campylobacter species from human and food-producing animal sources in Enugu State, Nigeria.Scientific reports · 2025Article
- Genotypic and Phenotypic Characterization of Antimicrobial Resistance and Virulence inAntibiotics (Basel, Switzerland) · 2025Article
- In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing onAntibiotics (Basel, Switzerland) · 2025Article
- The Impact of Antibiotic Resistance in Childhood Campylobacter Infections Before and After the COVID-19 Pandemic in the Southeast Region of Romania.Antibiotics (Basel, Switzerland) · 2025Article
- Review
- A Decade of Antimicrobial Resistance in Human and AnimalAntibiotics (Basel, Switzerland) · 2024Review
- Exploring the Role of the Environment as a Reservoir of Antimicrobial-ResistantMicroorganisms · 2024Article
- Persistence ofPathogens (Basel, Switzerland) · 2024Article
- Campylobacter occurrence and antimicrobial resistance profile in under five-year-old diarrheal children, backyard farm animals, and companion pets.PLoS neglected tropical diseases · 2024Article
- Exploring the Prevalence and Resistance ofVeterinary sciences · 2024Article
- Prevalence and Antimicrobial Resistance ofInfection and drug resistance · 2024Article
- The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021.EFSA journal. European Food Safety Authority · 2023Article
- Evolution and Role of Proteases inBiomolecules · 2023Review
- Distribution of Virulence Genes inBioMed research international · 2023Article
- Fast screening of enteropathogens in marine water samples.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022Article
- Should We Consider Them as a Threat? Antimicrobial Resistance, Virulence Potential and Genetic Diversity ofAntibiotics (Basel, Switzerland) · 2022Article
- Prevalence, species diversity, and antimicrobial susceptibility ofIranian journal of microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCampylobacteriosis is a dominant bacterial cause of foodborne infection and is considered the main public health problem in Europe and many other countries worldwide. In the study lasting from 2011 to 2013 we compared the prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children, domestic animals, poultry meat and surface water in Northern Poland.
resultsDuring a 3-years study 1973 samples were analysed. The results proved the presence of Campylobacter spp. in 306 (15.5%) samples. The percentage of Campylobacter-positive samples differed among the sample types, from 0% (freshwater beaches) to 38.6% (poultry meat in 2011). Prevalence of Campylobacter spp. in children isolates was 9.6%. It decreased from 13.2% in 2011 to 8.0% in 2013. It should be highlighted with a particular concern that Campylobacter jejuni was detected in 20.0% of fountains. All children and poultry meat isolates were susceptible to azithromycin. Two C. coli (3.7%) and four C. jejuni (3.3%) isolated from poultry meat were resistant to erythromycin. The highest percentage of C. jejuni isolates with resistance to ciprofloxacin were found in samples from 80% dogs and 85% ponds. Among isolates resistant to two antimicrobials 74.7% C. jejuni and 59.2% C. coli isolates were resistant to ciprofloxacin as well as to tetracycline. Only one cat C. coli isolate was resistant to both azithromycin and erythromycin. One C. jejuni isolate from a fountain was resistant to four antimicrobial agents (erythromycin, azithromycin, tetracycline and ciprofloxacin).
conclusionsThe study proved that surface water, poultry meat and pets constituted potential sources of Campylobacter to children. Fountains can be a direct source of children campylobacteriosis but can also pollute other environments with multidrug-resistant Campylobacter. The high resistance to some antimicrobials among the isolates may lead to increasing numbers of difficult-to-treat campylobacteriosis cases among children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.